Covered recipient · General Payments record
RAMESH B PERAMSETTY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$7,548.17
- Reported across 212 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $315.93 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | $95.94 | 2 |
| Astellas Pharma US Inc | $81.09 | 4 |
| MERZ NORTH AMERICA, INC. | $39.91 | 2 |
| Acerta Pharma LLC | $25.18 | 1 |
| Ardelyx, Inc. | $24.75 | 1 |
| Lilly USA, LLC | $17.87 | 1 |
| PFIZER INC. | $15.68 | 1 |
| ABBVIE INC. | $15.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.51 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105235099 | CMS |
| Ardelyx, Inc. | $24.75 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146700702 | CMS |
| Astellas Pharma US Inc | $19.06 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139366177 | CMS |
| Astellas Pharma US Inc | $20.88 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139374757 | CMS |
| Astellas Pharma US Inc | $18.45 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139384036 | CMS |
| Astellas Pharma US Inc | $22.70 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139432628 | CMS |
| AstraZeneca Pharmaceuticals LP | $25.18 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104284491 | CMS |
| Lilly USA, LLC | $17.87 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135354274 | CMS |
| MERZ NORTH AMERICA, INC. | $18.72 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146374176 | CMS |
| MERZ NORTH AMERICA, INC. | $21.19 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146374178 | CMS |
| PFIZER INC. | $15.68 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131758160 | CMS |
| REVANCE THERAPEUTICS, INC. | $57.45 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147926621 | CMS |
| REVANCE THERAPEUTICS, INC. | $38.49 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147926623 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.